ArticleScientific reports2025
Development and validation of predictive models for distant metastasis and prognosis of gastroenteropancreatic neuroendocrine neoplasms.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Development and validation of nomograms for distant metastasis and prognosis of small intestinal neuroendocrine tumors.Discover oncology · 2025Article
- Comparison of Mitotic Count and Ki-67 Index in Grading Gastroenteropancreatic Neuroendocrine Tumors and Their Association with Metastases.Biomedicines · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Imaging examinations exhibit a certain rate of missed detection for distant metastases of gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs). This study aims to develop and validate a risk prediction model for the distant metastases and prognosis of GEP-NENs. This study included patients diagnosed with gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) from the Surveillance, Epidemiology, and End Results (SEER) database between 2010 and 2015. External validation was performed with patients from the China-Japan Union Hospital of Jilin University. Univariate and multivariate logistic regression analyses were conducted on the selected data to identify independent risk factors for distant metastasis in GEP-NENs. A nomogram was subsequently developed using these variables to estimate the probability of distant metastasis in patients with GEP-NENs. Subsequently, patients with distant metastasis from GEP-NENs were selected for univariate and multivariate Cox regression analyses to identify prognostic risk factors. A nomogram was subsequently developed to predict overall survival (OS) in patients with GEP-NENs. Finally, the developed nomogram was validated using Receiver Operating Characteristic (ROC) curves, calibration curves, and Decision Curve Analysis (DCA). Kaplan-Meier analysis was employed to evaluate survival differences between high-risk and low-risk groups. A total of 11,207 patients with GEP-NENs were selected from the SEER database, and 152 patients from the China-Japan Union Hospital of Jilin University were utilized as an independent external validation cohort. Univariate and multivariate logistic regression analyses revealed that the primary tumor site, tumor grade, pathological type, tumor size, T stage, and N stage are independent predictors of distant metastasis in GEP-NENs. Additionally, among the 1732 patients with distant metastasis of GEP-NENs, univariate and multivariate Cox regression analyses identified N stage, tumor size, pathological type, primary site surgery, and tumor grade as independent prognostic factors. Based on the results of the regression analyses, a nomogram model was developed. Both internal and external validation results demonstrated that the nomogram models exhibited high predictive accuracy and significant clinical utility. In summary, we developed an effective predictive model to assess distant metastasis and prognosis in GEP-NENs. This model assists clinicians in evaluating the risk of distant metastasis and in assessing patient prognosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.